Navigation Links
Baby Quasar announces the launch of its next-gen skin care tool, Clear Rayz, for the treatment of acne
Date:11/26/2012

SARASOTA, Fla., Nov. 26, 2012 /PRNewswire/ -- The Clear Rayz represents a dramatic advance in acne care. Using both red and blue therapeutic light, the Clear Rayz helps to treat mild to moderate inflammatory acne. The treatment has none of the side effects that plague so many acne medications or topical products. It works on all skin types and ages from teen to adult.

(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-a)
(Photo: http://photos.prnewswire.com/prnh/20121126/FL17758-b)

Acne is the most common skin disorder. It affects most people at some point in their lives and has a significant impact on self-esteem. Current estimates suggest that consumers spend more than $250 million each year on acne treatments in the U.S. alone.

The Clear Rayz utilizes a patented double sided design that provides acne patients with the maximum light power to achieve the best results. The blue light kills the acne bacteria on the skin. The red light stimulates circulation, healing, and reduces inflammation commonly associated with acne breakouts. It is this combination of benefits that makes the Clear Rayz so unique.

Clear Rayz is classified as a Class II medical device and is cleared for treating mild to moderate inflammatory acne. Clear Rayz utilizes natural, safe, painless, high spectral purity light wavelengths, which are 415 and 660 nanometers. There are no harmful UV rays or irritating chemicals.  

About Quasar Bio-Tech Inc.
In 2007, Quasar Bio-Tech redefined skin care and put professional tools in the hands of consumers by introducing revolutionary new home use medical technology, the Baby Quasar. As an industry leader in premium consumer skin care tools, Quasar Bio-Tech continues its commitment to bring the highest quality professional type devices to the market through ongoing research and development. All Quasar Bio-Tech products are made in the USA.

 

 

 


'/>"/>
SOURCE Quasar Bio-Tech Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... New market research titled ... report that provides an overview of the Osteoarthritis,s ... identifying new targets and MOAs to produce first-in-class ... in this H1 2016 Osteoarthritis Pipeline report include ... Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, Inc., ...
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... ... President and CEO of EMED, today signed a multifaceted agreement which will allow ... the Northern Caribbean University Department of Natural and Applied Sciences, Allied Health and ...
(Date:4/29/2016)... ... 30, 2016 , ... Mercy College is expanding its Graduate Business Programs to ... expanding due to high demand: Master of Business Administration (MBA), Master of Organizational Leadership ... , School of Business Graduate Program Chair Dr. Ray Manganelli said: “We believe ...
(Date:4/29/2016)... ... 29, 2016 , ... Our bodies are bombarded daily by environmental and lifestyle ... these stressors is to adopt a more healthful diet, but too many people think ... certified Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) ... with sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, ... Run and Walk and 1-mile walk were held to increase awareness about Lyme ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Mobility Designed ... put pressure on the armpits, the M+D Crutch evenly distributes body weight from the ... wrists and hands when using the crutches than with other crutches. , Co-founders Max ...
Breaking Medicine News(10 mins):